Avacta Takeover Rumours (AVCT)

Why on earth would the shares be suspended for a takeover? I've never had that happen in any share I've had which has been subject to an offer.

The results are okay but not overly impressive. I expect 6000 to smash it out the park as it did pre-clinical and as it is in human as stabilised advanced and heavily treated tumours as well as significant reduction which is remarkable and not expected in the patient population.You should be more concerned about ICON and the other joke, 14p takeover nonsense. Be careful whitey. Remember you said you would invest here if dox not under patent. Deary me.